142 related articles for article (PubMed ID: 27590163)
1. Recombinant mumps viruses expressing the batMuV fusion glycoprotein are highly fusion active and neurovirulent.
Krüger N; Sauder C; Hoffmann M; Örvell C; Drexler JF; Rubin S; Herrler G
J Gen Virol; 2016 Nov; 97(11):2837-2848. PubMed ID: 27590163
[TBL] [Abstract][Full Text] [Related]
2. Functional properties and genetic relatedness of the fusion and hemagglutinin-neuraminidase proteins of a mumps virus-like bat virus.
Krüger N; Hoffmann M; Drexler JF; Müller MA; Corman VM; Sauder C; Rubin S; He B; Örvell C; Drosten C; Herrler G
J Virol; 2015 Apr; 89(8):4539-48. PubMed ID: 25741010
[TBL] [Abstract][Full Text] [Related]
3. Entry, Replication, Immune Evasion, and Neurotoxicity of Synthetically Engineered Bat-Borne Mumps Virus.
Krüger N; Sauder C; Hüttl S; Papies J; Voigt K; Herrler G; Hardes K; Steinmetzer T; Örvell C; Drexler JF; Drosten C; Rubin S; Müller MA; Hoffmann M
Cell Rep; 2018 Oct; 25(2):312-320.e7. PubMed ID: 30304672
[TBL] [Abstract][Full Text] [Related]
4. Cross-Neutralization between Human and African Bat Mumps Viruses.
Katoh H; Kubota T; Ihara T; Maeda K; Takeda M; Kidokoro M
Emerg Infect Dis; 2016 Apr; 22(4):703-6. PubMed ID: 26982800
[TBL] [Abstract][Full Text] [Related]
5. Protection of hamsters against experimental mumps virus (MuV) infection by antibodies raised against the MuV surface glycoproteins expressed from recombinant vaccinia virus vectors.
Houard S; Varsanyi TM; Milican F; Norrby E; Bollen A
J Gen Virol; 1995 Feb; 76 ( Pt 2)():421-3. PubMed ID: 7844562
[TBL] [Abstract][Full Text] [Related]
6. The F gene of rodent brain-adapted mumps virus is a major determinant of neurovirulence.
Lemon K; Rima BK; McQuaid S; Allen IV; Duprex WP
J Virol; 2007 Aug; 81(15):8293-302. PubMed ID: 17475640
[TBL] [Abstract][Full Text] [Related]
7. Characterization of mumps virus strains with varying neurovirulence.
Rafiefard F; Johansson B; Tecle T; Orvell C
Scand J Infect Dis; 2005; 37(5):330-7. PubMed ID: 16051568
[TBL] [Abstract][Full Text] [Related]
8. Novel polyvalent live vaccine against varicella-zoster and mumps virus infections.
Matsuura M; Somboonthum P; Murakami K; Ota M; Shoji M; Kawabata K; Mizuguchi H; Gomi Y; Yamanishi K; Mori Y
Microbiol Immunol; 2013 Oct; 57(10):704-14. PubMed ID: 23905963
[TBL] [Abstract][Full Text] [Related]
9. Replacement of the ectodomains of the hemagglutinin-neuraminidase and fusion glycoproteins of recombinant parainfluenza virus type 3 (PIV3) with their counterparts from PIV2 yields attenuated PIV2 vaccine candidates.
Tao T; Skiadopoulos MH; Davoodi F; Riggs JM; Collins PL; Murphy BR
J Virol; 2000 Jul; 74(14):6448-58. PubMed ID: 10864657
[TBL] [Abstract][Full Text] [Related]
10. Evolutionary analysis of mumps viruses of genotype F collected in mainland China in 2001-2015.
Cui A; Rivailler P; Zhu Z; Deng X; Hu Y; Wang Y; Li F; Sun Z; He J; Si Y; Tian X; Zhou S; Lei Y; Zheng H; Rota PA; Xu W
Sci Rep; 2017 Dec; 7(1):17144. PubMed ID: 29215070
[TBL] [Abstract][Full Text] [Related]
11. Chimeric bovine respiratory syncytial virus with attachment and fusion glycoproteins replaced by bovine parainfluenza virus type 3 hemagglutinin-neuraminidase and fusion proteins.
Stope MB; Karger A; Schmidt U; Buchholz UJ
J Virol; 2001 Oct; 75(19):9367-77. PubMed ID: 11533200
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies against the glycoproteins of mumps virus: fusion inhibition by anti-HN monoclonal antibody.
Tsurudome M; Yamada A; Hishiyama M; Ito Y
J Gen Virol; 1986 Oct; 67 ( Pt 10)():2259-65. PubMed ID: 3760826
[TBL] [Abstract][Full Text] [Related]
13. Vaccination with a human parainfluenza virus type 3 chimeric FHN glycoprotein formulated with a combination adjuvant induces protective immunity.
Garg R; Brownlie R; Latimer L; Gerdts V; Potter A; van Drunen Littel-van den Hurk S
Vaccine; 2017 Dec; 35(51):7139-7146. PubMed ID: 29153777
[TBL] [Abstract][Full Text] [Related]
14. Assessment of one-dose mumps-containing vaccine effectiveness on wild-type genotype F mumps viruses circulating in mainland China.
Cui A; Zhu Z; Mao N; Si Y; Ma Y; Hu Y; Deng X; Wang L; Zeng L; Zhang Y; Xu W
Vaccine; 2018 Sep; 36(38):5725-5731. PubMed ID: 30122648
[TBL] [Abstract][Full Text] [Related]
15. The Amino Acid at Position 8 of the Proteolytic Cleavage Site of the Mumps Virus Fusion Protein Affects Viral Proteolysis and Fusogenicity.
Hüttl S; Hoffmann M; Steinmetzer T; Sauder C; Krüger N
J Virol; 2020 Oct; 94(22):. PubMed ID: 32907974
[TBL] [Abstract][Full Text] [Related]
16. Differences in antigenic sites and other functional regions between genotype A and G mumps virus surface proteins.
Gouma S; Vermeire T; Van Gucht S; Martens L; Hutse V; Cremer J; Rota PA; Leroux-Roels G; Koopmans M; van Binnendijk R; Vandermarliere E
Sci Rep; 2018 Sep; 8(1):13337. PubMed ID: 30190529
[TBL] [Abstract][Full Text] [Related]
17. Sequence analysis of F, SH, and HN genes among mumps virus strains in Japan.
Kashiwagi Y; Takami T; Mori T; Nakayama T
Arch Virol; 1999; 144(3):593-9. PubMed ID: 10226622
[TBL] [Abstract][Full Text] [Related]
18. Genetic characterization of RS-12 (S-12), an Iranian isolate of mumps virus, by sequence analysis and comparative genomics of F, SH, and HN genes.
Alirezaie B; Aghaiypour K; Shafyi A
J Med Virol; 2008 Apr; 80(4):702-10. PubMed ID: 18297711
[TBL] [Abstract][Full Text] [Related]
19. A 176 amino acid polypeptide derived from the mumps virus HN ectodomain shows immunological and biological properties similar to the HN protein.
Herrera E; Barcenas P; Hernández R; Méndez A; Pérez-Ishiwara G; Barrón B
Virol J; 2010 Aug; 7():195. PubMed ID: 20727167
[TBL] [Abstract][Full Text] [Related]
20. Genetic variation in the HN and SH genes of mumps viruses: a comparison of strains from mumps cases with and without neurological symptoms.
Cui A; Brown DW; Xu W; Jin L
PLoS One; 2013; 8(4):e61791. PubMed ID: 23637906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
